Kaleidoscope
Private Company
Total funding raised: $5M
Overview
Kaleidoscope is a private, pre-revenue platform technology company founded in 2019 and headquartered in San Francisco. It has developed a cloud-based SaaS platform designed to orchestrate data and workflows across the life science R&D value chain, from internal project management to secure collaboration with external Contract Research Organizations (CROs). The platform centralizes experiment tracking, inventory management, assay cascades, and design-make-test-analyze (DMTA) cycles, promising to accelerate timelines, reduce costs, and improve data compliance. Its target customers are biotechnology and pharmaceutical companies pursuing drug development across various modalities.
Technology Platform
A cloud-based data and work orchestration platform for life science R&D. It integrates with existing tools to manage internal workflows and external CRO collaborations, featuring modules for request management, assay cascades, entity registry, inventory tracking, DMTA cycle management, and customizable dashboards. Offers API access and secure deployment options (cloud, single-tenant, on-prem).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Kaleidoscope competes with a fragmented set of point solutions, including electronic lab notebooks (ELNs like Benchling, Dotmatics), laboratory information management systems (LIMS), and project management software. Its key differentiation is the focused integration of internal workflow orchestration with secure external CRO collaboration and specific drug discovery modules (DMTA, assay cascades) in a single platform.